Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by SizzlinSteakson Apr 16, 2018 8:03pm
127 Views
Post# 27894520

RE:RE:Someone wants this low, but only for the time being

RE:RE:Someone wants this low, but only for the time beingSo in the next couple of days we could potentially see 14 or 15 cents before moving back up.
Maybe time to put some serious bids in...hmmmm?

indaknownewfie wrote:
yorgosGK wrote:

THIS IS ALL IN MY OPINION - NO CONCRETE EVIDENCE, PURELY SPECULATION OF WHAT I THINK IS HAPPENING......

Someone wants this low to cash in after this week. It's in someones interest....Look at the filtered sell trades below....Oh and by the way - 018 broker ID is Echelon Wealth (the guys about to get their hands on warrants @.13 and debentures).

Today's trades from 018 (notice the filter date - no sell trades came before April 10th 2018, the start of our decline). 

**right click and open in a new tab to zoom in**
User image

In my opinion (and if Echelon was smart) - all things point to getting shorted out soon at a low level , to skyrocket (coincidently in time for the 21st). I'm here for the ride - top up people. Not going to get into this more because its speculation and not fair to point fingers without concrete evidence, but I hope people can put 2 and 2 together and play it how they want.

We all know KALY is a winner no matter what. This noise has to be put to sleep though. Will be an interesting next 2 weeks to say the least. Stay for the ride; your probobly going to want to. Cheers. 

 


Best analysis i have seen of the current sp fluctuations EOM 


Bullboard Posts